Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 3;11(7):1881.
doi: 10.3390/biomedicines11071881.

Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma

Marc-Eric Halatsch  1
Affiliations
Editorial

Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma

Marc-Eric Halatsch. Biomedicines. .

Abstract

Despite advances in local treatments, such as supramaximal resection (even in eloquent locations [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Di L., Shah A.H., Mahavadi A., Eichberg D.G., Reddy R., Sanjurjo A.D., Morell A.A., Lu V.M., Ampie L., Luther E.M., et al. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: Safety and improved survival over gross-total resection. J. Neurosurg. 2022;138:62–69. doi: 10.3171/2022.3.JNS212399. - DOI - PubMed
    1. Brendle C., Maier C., Bender B., Schittenhelm J., Paulsen F., Renovanz M., Roder C., Castaneda-Vega S., Tabatabai G., Ernemann U., et al. Impact of 18F-FET PET/MRI on clinical management of brain tumor patients. J. Nucl. Med. 2022;63:522–527. doi: 10.2967/jnumed.121.262051. - DOI - PMC - PubMed
    1. Stupp R., Taillibert S., Kanner A., Read W., Steinberg D., Lhermitte B., Toms S., Idbaih A., Ahluwalia M.S., Fink K., et al. Effect of tumor-treating fields plus maintenance temozolomide vs. maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial. JAMA. 2017;318:2306–2316. doi: 10.1001/jama.2017.18718. - DOI - PMC - PubMed
    1. Rong L., Li N., Zhang Z. Emerging therapies for glioblastoma: Current state and future directions. J. Exp. Clin. Cancer Res. 2022;41:142. doi: 10.1186/s13046-022-02349-7. - DOI - PMC - PubMed
    1. Mandel J.J., Yust-Katz S., Patel A.J., Cachia D., Liu D., Park M., Yuan Y., Kent T.A., de Groot J.F. Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro Oncol. 2018;20:113–122. doi: 10.1093/neuonc/nox144. - DOI - PMC - PubMed

Publication types

LinkOut - more resources